US2016000731A1PendingUtilityA1
Sore-throat compositions and related methods
Est. expiryJul 2, 2034(~8 yrs left)· nominal 20-yr term from priority
A61K 47/10A61K 31/047A61K 36/61A61K 36/23A61K 9/0053A61K 36/484A61K 45/06A61K 31/7004A61K 36/53A61K 36/28
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for alleviating sore throat conditions and related compositions. In some such compositions, at least one non-hexose sugar alcohol and/or at least one non-hexose sugar alcohol precursor may be present in a concentration effective for reducing a concentration of sore-throat causing microorganisms in a patient's throat. The composition may further comprise at least one coating agent in a concentration effective for prolonging the presence of the at least one non-hexose sugar alcohol and/or at least one non-hexose sugar alcohol precursor in a patient's throat to treat the sore throat condition.
Claims
exact text as granted — not AI-modified1 . A method for treating a sore throat condition, the method comprising the steps of:
identifying a subject having a sore throat condition; providing a composition comprising at least one of a non-hexose sugar alcohol and a non-hexose sugar alcohol precursor, wherein the at least one of a non-hexose sugar alcohol and a non-hexose sugar alcohol precursor is present in a concentration of between about 10% and about 60% by weight; and delivering the composition into the subject's throat to treat the sore throat condition.
2 . The method of claim 1 , wherein the composition comprises at least one of a non-hexose sugar alcohol and a non-hexose sugar alcohol precursor in a concentration of between about 20% and about 55% by weight.
3 . The method of claim 2 , wherein the composition comprises at least one of a non-hexose sugar alcohol and a non-hexose sugar alcohol precursor in a concentration of about 50% by weight.
4 . The method of claim 1 , wherein the at least one of a non-hexose sugar alcohol and a non-hexose sugar alcohol precursor comprises only at least one non-hexose sugar alcohol.
5 . The method of claim 4 , wherein the at least one non-hexose sugar alcohol comprises only at least one of xylitol and erythritol.
6 . The method of claim 5 , wherein the at least one non-hexose sugar alcohol comprises only xylitol.
7 . A method for treating a sore throat condition, the method comprising the steps of:
identifying a subject having a sore throat condition; providing a composition comprising:
at least one of xylitol, xylose, erythritol, ribose, and arabinose in a concentration of between about 20% and about 55% by weight; and
at least one coating agent comprising at least one of glycerin, sodium alginate, propylene glycol, and carboxymethylcellulose sodium in a concentration effective for prolonging the presence of the at least one of xylitol, xylose, erythritol, ribose, and arabinose in a patient's throat to treat the sore throat condition; and
delivering the composition into the subject's throat to treat the sore throat condition.
8 . The method of claim 7 , wherein the at least one of xylitol, xylose, erythritol, ribose, and arabinose comprises only xylitol.
9 . The method of claim 8 , wherein the composition comprises xylitol in a concentration of about 50% by weight.
10 . The method of claim 7 , wherein the composition comprises at least one of xylitol, xylose, erythritol, ribose, and arabinose in a concentration of about 50% by weight.
11 . The method of claim 7 , wherein the composition comprises a viscosity of between about 50 and about 300 centipoise at room temperature.
12 . A composition for alleviating a sore throat condition, the composition comprising:
at least one non-hexose sugar alcohol in a concentration effective for reducing a concentration of sore-throat causing microorganisms in a patient's throat; and at least one coating agent in a concentration effective for prolonging the presence of the at least one non-hexose sugar alcohol in a patient's throat to treat the sore throat condition.
13 . The composition of claim 12 , wherein the at least one coating agent comprises at least one of glycerin, sodium alginate, propylene glycol, and carboxymethylcellulose sodium.
14 . The composition of claim 12 , further comprising at least one of an expectorant, an anti-mucosal agent, and a mucolytic agent.
15 . The composition of claim 14 , wherein the at least one of an expectorant, an anti-mucosal agent, and a mucolytic agent comprises at least one of eucalyptus oil, licorice root, guaifenesin, guaiacum, phenylephrine HCL, echinacea, and holy basil.
16 . The composition of claim 12 , further comprising an antibacterial agent.
17 . The composition of claim 16 , wherein the antibacterial agent comprises at least one of an anise seed extract, a star anise extract, and propolis.
18 . The composition of claim 17 , wherein the antibacterial agent comprises anise oil.
19 . The composition of claim 12 , wherein the composition comprises a viscosity of between about 50 and about 300 centipoise at room temperature.
20 . The composition of claim 19 , wherein the composition comprises a viscosity of between about 80 and about 200 centipoise at room temperature.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.